Matthew Baggott, PhD, is a neuroscientist and CEO of Tactogen, a public benefit corporation that is developing MDMA-like medicines with a goal of making transformative experiences safer, more effective, and more accessible. He studied philosophy at the University of Chicago, earned a PhD in neuroscience at UC Berkeley, and has conducted studies administering compounds such as MDMA and MDA to healthy volunteers.